ARCHIVE

• BUSINESS NEWS IN BRIEF -2-
  April 23, 2001

• Ain Pharmaciez, Nice Drug to Jointly Operate Large Dispensing Pharmacies in Tokai
  April 23, 2001

• CORPORATE ROUNDUP NEWS IN BRIEF
  April 23, 2001

• DIAGNOSTICS NEWS IN BRIEF
  April 23, 2001

• NEW PRODUCTS NEWS IN BRIEF
  April 23, 2001

• Kureha, Sankyo Tie Up for Joint Development of CXCR4 Blocker
  April 23, 2001

• Patients"Success Rate Increases to Record High in 2000: Malpractice Lawsuits
  April 23, 2001

• Hitachi, Myriad, Oracle, Friedli to Tie Up in Proteomics
  April 16, 2001

• JPA Leader Comments on New Deregulation Promotion Plan
  April 16, 2001

• Sankyo to Be Aggressive in Genomic Drug Discovery: Dr Hiraoka
  April 16, 2001

• Toyama to Exclusively Market YP-14 Jointly Developed with Taiho
  April 16, 2001

• Review of NHI Price System Included in New Deregulation Plan
  April 16, 2001

• Daiichi, Medtronic Codevelop Intrathecal Baclofen Therapy
  April 16, 2001

• Novartis to Double Sales in 5 Years in Transplantation, Immunology, Cancer
  April 16, 2001

• REGULATORY NEWS IN BRIEF -1-
  April 16, 2001

• Kirin Brewery to Survive by Focusing on Cancer, Nephrology, Allergy/Immunology
  April 16, 2001

• The Cues in Pharma Communication (2)
  April 16, 2001

• Quintiles to Double Its Sales in Japan in FY2001
  April 16, 2001

• REGULATORY NEWS IN BRIEF -2-
  April 16, 2001

• Immediate PMS of Mobic Undertaken by Nippon Boehringer Ingelheim, Daiichi
  April 16, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 761
• 762
• 763
• 764
• 765
• 766
• 767
• 768
• 769
• …
• Next ›
• 最終 »